In PCOS patients, chronic hyperinsulinemia and hormonal imbalances may further exacerbate these molecular abnormalities, enhancing the activation of the PI3K/AKT and MAPK pathways, thus increasing the risk of cancer development. This evidence concerns the gene AKT1 and Hyperinsulinemia.